Trudy D. Helge, PsyD Postdoctoral Fellow in Clinical/Health Psychology, Co-Director, Cleveland Clinic Smoking Cessation Program, Department of Psychiatry and Psychology, Cleveland Clinic
Garland Y. DeNelsky, PhD Director, Cleveland Clinic Smoking Cessation Program, Department of Psychiatry and Psychology, Cleveland Clinic
Address: Garland Y. DeNelsky, PhD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; denelsg@ccf.org
ABSTRACT
Nicotine replacement and bupropion have shown significant benefits for those seeking pharmacologic assistance with smoking cessation. This discussion reviews the efficacy literature for both treatments, including potential side effects.
